|
|
12780 El Camino Real
San Diego, CA 92130 USA
phone:(858) 658-7600
fax:(858) 658-7601
|
|
| Symbol |
NBIX |
| Exchange |
NASDAQ |
| Founded |
0 |
| Employees |
253 |
|
|
| www.neurocrine.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Drugs for neurologic and endocrine system-related diseases. |
|
| Management |
| Kevin C. Gorman, Ph.D., President, Chief Executive Office; Margaret Valeur-Jensen, J.D., Ph.D., Executive Vice President; Tim Coughlin, C.P.A., Vice President, Chief Financial Officer; Dr. Christopher O'Brien, Chief Medical Officer; Haig Bozigian, Ph.D., Senior Vice President of Pharmaceutical and Preclinical Development |
| |
|
|
|
|
|
|
|
| Keywords |
| irritable bowel syndrome, anxiety, depression, pain, diabetes, |
|
|
|
| Description |
|
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. |
|
| Products / Services |
Their product candidates address pharmaceutical markets in the world including insomnia, certain female and male disorders, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available by clicking on Press Releases in the menu on the left.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
